Board

12 Sep, 2019

Karin Eastham

Karin Eastham has served on our board since September 2019. Ms. Eastham has over 35 years of experience in financial and operations management, primarily in life sciences companies. Ms. Eastham serves as a director for 3 additional public biotechnology companies, Nektar Therapeutics, Geron Corporation, and Veracyte, Inc. Her former public directorships include Illumina, Inc., MorphoSys [...]

20 Jun, 2019

Paul Ricci

Mr. Ricci has served on our board of directors since February 2019. Since October 2018, Mr. Ricci has served as an Advisor to Lightspeed Venture Partners, an early-stage technology venture capital firm. Since September 2018, Mr. Ricci has served as an Advisor to Warburg Pincus, a private equity firm. Mr. Ricci served as Chief Executive Officer of Nuance Communications, [...]

20 Jun, 2019

A. Blaine Bowman

Mr. Bowman has served on our board of directors since May 2019. Beginning in 2006, Mr. Bowman served on the board of directors of Solexa, Inc., a DNA sequencing company, until its sale to Illumina, Inc., a biotechnology company, after which Mr. Bowman continued to serve on the board of directors until May 2018. From March 1977 to August 2005, [...]

20 Aug, 2017

Ken Ludlum

Mr. Ludlum has served on our board of directors since July 2015. Mr. Ludlum also currently serves on the board of directors of NATUS Medical, Inc., a medical equipment company, IRIDEX Corporation, a medical device company and Dermavant Sciences Ltd, a biopharmaceutical company. From February 2014 to April 2016, Mr. Ludlum served as Chief Financial Officer [...]

20 Aug, 2017

Patrick J. Balthrop, Sr.

Patrick J. Balthrop, Sr. is the founding principal of Apalachee Ventures. He has over 30 years of experience building, growing and optimizing businesses in the healthcare sector, particularly in the life sciences segments of diagnostics, life science tools and medical devices. Previously, Mr. Balthrop was CEO, President and Director of Luminex Corporation, a publicly-traded diagnostics, [...]

17 Aug, 2017

John West

Personalis’ CEO, John West, first became involved in DNA sequencing and DNA sequence interpretation in 1982. In the 1980’s, he led the development of an automated DNA sequencing system based on pattern recognition from autoradiographs, and licensed software from the lab of Roger Staden at MRC Cambridge, UK for sequence assembly and analysis. In the [...]

Go to Top